Skewing the aim of targeted cancer therapies

The aim of targeted gene-based cancer therapies could often be skewed from the start. A widespread concept about how cells produce proteins proved incorrect 62 percent of the time in a new study in ovarian cancer cells on the relationship between RNA and protein levels. (Mehr in: Cancer News — ScienceDaily)